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Eng Eong OoiAbstract
The number of reports in the literature on dengue outbreaks in various parts of south China is increasing. This
trend is likely contributed to by multiple factors, chief among which is the increase in trade and human movement
in and out of China from the Southeast Asian region where dengue is firmly endemic. However, a holistic picture of
dengue in China and how the public health authorities are responding to this global health challenge has been
missing. In a research article published in BMC Medicine, Lai et al. have now filled this gap in knowledge by
analysing statutorily mandated national dengue surveillance data from 1990 till 2014. They also conducted time
series analyses to identify key drivers of dengue transmission in south China as well as from south China to the
other parts of this vast and populous country. Their findings, as well as the description of surveillance and disease
control activities in China, highlight urgent steps that need to be taken if China wishes to prevent itself from
becoming another country that experiences large and frequent cycles of epidemic dengue.
Please see related article: http://dx.doi.org/10.1186/s12916-015-0336-1.
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Dengue in China has a long history. Clinical description
consistent with dengue was recorded during the Jin
Dynasty in A.D. 265 to 420 and one of the earliest den-
gue epidemics occurred in A.D. 992, both in China [1].
The emergence of three- to five-year cycles of epidemic
dengue in the latter half of the 20th century has, how-
ever, spared China. Indeed, the epicentre of the emer-
gence of cyclical dengue epidemics began in Southeast
Asia, immediately south of China, after World War II
(WWII). The movement of troops and war materiel in-
troduced both the vector, Aedes aegypti, and the dengue
virus (DENV) into this region of the world. The post
war recovery resulted in intensive urbanisation in cities
such as Manila, Bangkok and Kuala Lumpur. Urbanisa-
tion allowed the highly domesticated A. aegypti mos-
quito to thrive and the increasing human population
density provided susceptible hosts for all four serotypes
of DENV [2]. From this foothold and starting in the
1950s, cyclical epidemic dengue spread to the rest of the
tropical and subtropical world, except, perhaps, China.
China borders several Southeast Asian countries,
namely Vietnam, Laos and Myanmar. It also bordersCorrespondence: engeong.ooi@duke-nus.edu.sg
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China has a humid subtropical climate and is on the
same latitude as south Taiwan and Mexico, where
repeated dengue epidemics have been reported. South
China also has a number of densely populated urban
centres, such as Guangdong and Shenzhen. Despite
these favourable contexts for dengue transmission,
dengue cases and epidemics have only been reported
sporadically in China, until now.
In a research article in BMC Medicine, Lai et al. pro-
vide a comprehensive description of dengue incidence in
China [3]. Dengue became a legally mandated notifiable
disease in China in 1989 after its re-emergence in 1978.
Lai and colleagues obtained and analysed all notified
cases of dengue from 1 January 1990 to 31 December
2014. They show that the average annual incidence rate
of dengue is 2.2 cases per million persons, although the
incidence showed an increasing trend since 2012, peak-
ing in 2014 with a record high of over 34.4 cases per
million persons. Time series analyses of the reported
dengue cases indicated that indigenous cases occurred
mostly between July and November. These indigenous
cases were often preceded by reports of imported den-
gue cases. As expected, the provinces with the highest
incidence of dengue were those that border Southeast
Asian countries. All four DENV serotypes have beenn Open Access article distributed under the terms of the Creative Commons
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and westwards in China. The trends since 2012 could
thus be a harbinger of cyclical epidemic dengue in
China.
Why is epidemic dengue a relatively latecomer in China
despite its proximity to Southeast Asia?
For many years post WWII, international trade and
travel to and from China were limited due to economic
ideals and policies instituted under the Chairmanship of
Mao. Besides economic isolation, these policies probably
also served to limit the introduction of DENV through
asymptomatic or pre-symptomatic travellers into China
via the big Southeast Asian cities. The gradual opening
up of China economically under the leadership of Deng
Xiaoping, from 1978 until 1992 led to more open trade
and travel [4] and this policy continues to be in place
presently. It is thus not completely surprising that out-
breaks occurred from 1978 onwards. However, it has
also to be said that the lack of reports of disease does
not invariably mean low disease incidence. The types,
quality and intensity of surveillance activities are also
critical factors and these will be discussed later.
What are the implications of re-emergence of dengue
in China?
South China has several large cities. Guangzhou and
Shenzhen each has more than 10 million inhabitants.
These cities and many more are growing economically
and the size and population densities are set for expan-
sion. These factors could provide environments that are
even more conducive for DENV transmission and,
hence, more frequent and larger epidemics can be ex-
pected in the coming years. Instead of merely being on
the receiving end of imported dengue, south China
could become a nidus of dengue transmission, not only
to other parts of China but also to the rest of the world.
What then should our response be?
Besides describing the scale of the problem, Lai and
colleagues also highlight areas in disease and vector sur-
veillance for improvement [3]. Dengue surveillance in
China, as in many countries, is passive. This likely con-
tributes to significant underestimation of the true bur-
den of disease. Given the non-specific clinical features of
dengue, especially in the early phase of illness, a more
active approach to dengue surveillance will be needed to
obtain a more accurate epidemiological picture [5]. In-
deed, the low incidence of dengue in the 1990s despite
the use of clinical diagnostic criteria alone suggests that
awareness of dengue may not be high. The use of clinical
diagnosis without laboratory confirmation would pro-
duce a high sensitivity but poor specificity for acute den-
gue [6] and this should have led to over-diagnosis ofdengue until the introduction of laboratory confirmatory
tests. That this trend did not occur underscores the need
for a greater level of outreach by the public health au-
thorities to physicians working at all levels of healthcare
to raise awareness. Likewise, the use of active surveil-
lance in selected locales could also provide more refined
data on the true burden of dengue in China [3].
Unhelpful criteria for classifying dengue should also be
removed. A major problem is the requirement of a recall
of mosquito bite within 15 days of illness onset. This re-
quirement likely introduces recall bias into the surveil-
lance data. Moreover, the night time buzz or bites of
mosquitoes that then wake a person are more likely to
be remembered than those that occur during the day-
time, which is when the peak biting activity of A. aegypti
and A. albopictus occurs. This inclusion criterion thus
introduces unnecessary inaccuracies into the surveil-
lance data.
Finally, the scale of vector surveillance and population
control will also need to be ramped up significantly. Lai
et al. noted that out of 483 counties in the five provinces
in south China, only 16 conducted vector surveillance.
This is clearly insufficient to prevent dengue. The au-
thors also reported that only one province, Hainan, is
infested with A. aegypti. All others have only reported
A. albopictus infestation. It is plausible that, with the
limited surveillance, the geographic spread of A. aegypti,
which display biological and behavioral features that
make it the more effective DENV vector [7], is currently
underestimated. Furthermore, without systematic sur-
veillance, the spread of A. aegypti through the move-
ment of goods and other materials into new parts of
China would also go undetected until a dengue epidemic
is well underway. When this happens, any emergency
vector control response would often be too little too late.
Given the scale of expansion of the highly urbanised and
populated areas in south China, steps to rectify this gap
in surveillance should be taken urgently.Competing interests
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